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Introduction 
ancer is a serious health problem 
worldwide, imposing a large economical 
and psychological burden as well as loss 
of life and productivity.1 Lots of effort and money 
have been put in the fields of clinical, 
epidemiological, pharmacological, and biological 
research on cancer in the recent decades. Although 
we have witnessed dramatic progress in the field, 
but still there is a long way to go. Cancer is the 
third most common cause of death in Iran, 
accounting for 14% of the total death toll.2 It 
stands just after cardiovascular events and 
accidents (46% and 17% of the total death toll 
respectively, Table 1) according to the latest 
census of the Iranian Ministry of Health and 
Medical Education (IMHME). Overall, 
gastrointestinal (GI) cancers cause about half of all 
cancer deaths in Iran. Of the 17,450 GI cancers 
recorded in the IMHME report, 7,560 (43.3%) 
were gastric cancers.2 In other words, of every 100 
people dying of cancer in Iran, 22 die of gastric 
cancer, and six from esophageal cancer. 
Unfortunately, both of these cancers come to 
medical attention when they are rather advanced 
and limited or no effective therapies are available 
for them. Theoretically, these cancers may be 
treatable in their early stage; therefore, finding 
them at the earliest possible stage may subject 
them to effective therapy. Other nations, such as 
the Japanese, have managed to decrease the toll of 
gastric cancer by effective screening programs and 
timely intervention.3 Therefore, if we are to plan 
meaningfully to combat this still deadly disease we 
should have accurate information about the 
epidemiology and clinical characteristics of 
various cancers, especially the upper GI cancers in 
Iran. 
Earlier reports indicated that Ardabil, in North-
West of Iran, had a rather high incidence of upper 
GI cancers. 4 – 8 In their 1973 report, Mahboubi et 
al reported that about 64% of all cancer deaths in 
Ardabil are due to esophageal and gastric cancers 
(56% esophagus and 8% stomach).4 This 
background and the availability of facilities of a 
collaborating local medical university and easy 
means of air travel to the area made Ardabil an 
appropriate place for epidemiological and clinical 
cancer studies in the past few years. This review 
focuses on the background and recent studies done 
in the region as a model of cancer research in Iran. 
 
Background  
The Public Health Research Institute (PHRI) of 
Tehran University and the International Agency for 
Research on Cancer (IARC) jointly established a 
cancer registry in the city of Babol in Mazandaran 
Province in the Caspian littoral in 1969.8 The 
registry mainly covered the two provinces of Gilan 
and Mazandaran, and the nearby city of Ardabil. 
Information gathered by this cancer registry soon 
showed an unusually high incidence of esophageal 
cancer in the Caspian Littoral. Interestingly the 
distribution was rather uneven. The western parts 
of the Littoral (Ardabil) had a high incidence (age 
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Table 1. The most common causes of death in 
Iran (2000). 
Etiology Percentage 
CVD 46% 
Accident 17% 
Cancer 14% 
Respiratory 6% 
Others 17% 
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standardized ratio (ASR): 20.1 and 6.2 per 100,000 
population for men and women, respectively), 
while the central parts had a lower incidence 
(ASR: 13.0 and 2.3 per 100,000 for males and 
females, respectively), and the eastern parts had an 
unusually high incidence (ASR: 165.5 and 195.3 
per 100,000 for men and women, respectively).4 – 8 
This was especially evident in the Turkman plain 
in the East of the littoral having the above-
mentioned ASR which was among the highest ever 
recorded in the world. Another point of interest 
was that esophageal cancer was more common 
among Turkman females. This cancer registry 
relied on clinical and simple radiological means for 
recording the final diagnoses, as endoscopy was 
not available, and surgery and histological 
diagnosis were not easily accessible locally. 
However, despite this shortcoming, it managed to 
draw the attention of interested national and 
international investigators who launched studies to 
unravel the possible risk factors for this high 
incidence of esophageal cancer in the region. 
These efforts came to a temporary halt during the 
revolution in 1979, but after a decade, a new 
generation of scientists restarted working in this 
field. 
 
Geographical and demographic situation of 
the Ardabil Province  
The Ardabil Province, a mountainous land, with 
an area of 1,795 square kilometers (1.09% of the 
country’s surface area), is located in the North-
West of Iran, 50 km inland to the West of the 
Caspian Sea. The city of Ardabil, the capital of the 
province is located at 38° 14′ 32″ latitude N and 
48° 17′ 53″ longitude E. Mount Sabalan, a dormant 
volcano, is located just beside the city of Ardabil. 
The climate is moderate with cold winters and cool 
summers. According to the 1999 census, the total 
population of the province is 1,128,864 (1.94% of 
the country’s population), 46% of whom live in 
nine cities and the rest (54%) reside in rural areas. 
The majority of the population (more than 95%) is 
of Azari ethnicity, a branch of the Aryan 
Caucasoids. Therefore, the Azari language is the 
dominant language and all the residents are 
Muslims. Mean age of the population is 23 years 
and 63% of the population are below 25 years of 
age. Life expectancy at birth is 60 years for men 
and 61 years for women. Two-thirds of the males 
are farmers and 90% of females are housewives. 
The remainders are local industrial workers, white 
collars, or executives. At the present time there are 
21 outpatient clinics, 340 private offices, 49 
medical laboratories, 7 histopathology laboratories, 
and 18 radiology centers actively working in the 
region, providing health services. 
 
The new era 
Having this background and a very low 
migration rate as well as easy access to the region 
and presence of an enthusiastically collaborating 
local medical university, made Ardabil an 
appropriate place to continue what was started 
almost three decades before. Therefore, the 
Digestive Disease Research Center (DDRC) of 
Tehran University of Medical Sciences (TUMS) 
launched a series of large-scale studies in the 
region with collaboration of Ardabil University of 
Medical Sciences and the National Cancer Institute 
(NCI, National Institute of Health, USA) and 
International Agency for Research on Cancers 
(IARC) (Lyon, France). These studies, which 
started in the autumn of 1999, were aimed to 
answer the following questions: 
• What are the current incidence, prevalence, and 
mortality rates of esophageal and gastric cancer 
in the Ardabil Province? 
• What is the prevalence of precancerous lesions 
(e.g. dysplasia, intestinal metaplasia…) in the 
population? 
• What are the probable risk factors for 
developing upper GI cancers in this area? 
• What preventive and therapeutic strategies may 
be the best to decrease the burden of disease in 
the region? 
To answer these questions, to generate new 
hypotheses, and to find new appropriate questions, 
several projects were started in parallel. 
An active cancer surveillance program9 covering 
the years of 1996 to 1999, including about 14% of 
the total Iranian population, was launched in 5 
provinces, one of which was Ardabil. The findings 
were rather interesting. This active surveillance 
showed that upper GI cancers (Table 2) are the 
most common cancers in the Ardabil among both 
females and males (skin cancers excluded). The 
registry showed that the annual ASR for all types 
of cancer was 132.0 per 100,000 population among 
males and 96.3 per 100,000 population among 
females. The most common cancers in men were 
stomach (ASR: 49.1/100,000), esophagus (ASR: 
15.4/100,000), lung (ASR: 7.9/100,000), colorectal 
(ASR: 7.9/100,000), and urinary bladder (ASR: 
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7.6/100,000). Similar figures for females were as 
follows: stomach (ASR: 25.4/100,000), esophagus 
(ASR: 14.4/100,000), breast (ASR: 7.6/100,000), 
colon and rectum (ASR: 5.9/100,000), and lung 
(ASR: 3.6/100,000). Comparison of these data 
with those of Babol Cancer Registry reveals that 
the incidence of upper GI cancers in Ardabil has 
increased by 48% and 39% among males and 
females, respectively. Interestingly the incidence 
of esophageal cancer has actually declined while 
the incidence of gastric cancer has risen sharply, 
accounting for most of the increase in overall 
incidence. Currently gastric cancer accounts for 
37% of all cancers in men and 25% of all cancers 
in women in Ardabil (as compared to 11% and 
14%, respectively in the early 70s).4, 8 The new 
cancer registry tried to have as accurate data as 
possible; therefore every effort was made to 
include all cases of cancer in the area, even those 
seeking medical advice in Tehran and Tabriz (the 
two major cities where patients may seek medical 
advice out of Ardabil). Overall, 3,455 cases of 
cancer were diagnosed in the study period. In this 
new cancer registry, 89.8% of cases had 
histological confirmation of their diagnoses, 9.1% 
had clinical diagnoses merely, and only 1.1% of 
records relied on death certificates. This is in 
contrast to the Babol Cancer Registry where only 
27% of cases had a confirmed histological 
diagnosis. This reason as well as better and more 
widespread availability of medical care facilities in  
the region resulting in earlier and more accurate 
diagnoses, may account for a part of the difference 
between the results of the two cancer registries, but 
certainly not the whole change. Considering all 
confounders, a major part of this change can only 
be explained by a true change in the incidence of 
various upper GI cancers. These new data show 
that the ASR for gastric cancer in Ardabil is the 
fourth highest ever recorded worldwide (after 
Japan, Korea, and Costa Rica). Therefore, further 
studies to look for the etiology and possible risk 
factors, and precancerous lesions seemed logical. 
To support this was the findings of a serologic 
study done earlier showing that Helicobacter 
pylori (HP), a well-known class-one carcinogen for 
gastric cancer, was significantly more prevalent in 
Ardabil than in other parts of the country which 
have a lower incidence of gastric cancer (like Yazd 
in central Iran).10 Of over 350 individuals younger 
than 20 years tested for HP antibodies in their sera 
in each region, 47.5% and 30.6% were positive in 
Ardabil and Yazd,   respectively (p < 0.0001). But 
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similar studies from Fars and Tehran Provinces 
(with lower incidence of gastric cancer than 
Ardabil) did not show any difference in serologic 
prevalence of HP with Ardabil. Therefore, looking 
for other causes possibly related to gastric cancer 
in the region and their interactions with each other 
and HP is justified. 
Another series of studies done in the region 
were two successive endoscopic surveillance 
studies performed in Ardabil and Meshkinshahr.10– 
11 The aim of these studies was to look for 
precancerous lesions and possible risk factors. In 
these studies healthy people from the two regions 
were invited to undergo a medical examination and 
fill in a detailed questionnaire (covering 
demographics, dietary habits, lifestyle, occupation, 
major upper GI and non-GI symptoms, and family 
history of benign and malignant diseases). In 
addition, they were offered to undergo an upper GI 
endoscopy with Lugol’s staining of the esophagus 
and systematic biopsies of the esophagus and 
stomach to look for precancerous lesions. Overall, 
1,105 urban and rural households were selected by 
random cluster sampling and one person aged 40 
years or older from each household was asked to 
participate. A total of 1,011 people were enrolled 
(among a population of 599,494). Of the 504 
people studied in Ardabil, 36% had endoscopic 
esophagitis (mostly grades A and B according to 
the Los Angeles classification). None of them had 
dysplasia or squamous cell carcinoma in the 
esophagus and Lugol’s staining did not pick up any 
precancerous lesion not seen on routine endoscopy. 
Ninety-five percent of the 1,011 subjects 
undergoing endoscopy in the two regions had 
active or inactive gastritis on histological 
examination. This is very important, as most of 
these were associated with HP (89%). Other 
findings in the stomach of these subjects were 
atrophy (38%), intestinal metaplasia (9%), 
glandular dysplasia (0.2%), and adenocarcinoma 
(0.3%). It should be reemphasized that none of 
these people had sought medical advice for any GI 
problem. In other words all of them were either 
asymptomatic or had only trivial GI symptoms not 
taking them to a doctor. Absence of precancerous 
esophageal lesions and a wide-spectrum of 
different types of pathologies found in the stomach 
support the findings of the mentioned cancer 
registry, which shows a decline in the incidence of 
esophageal cancer and a rise in that of gastric 
cancer in the region.  
The latest study of these series has been done in 
the Aras Clinic.12 – 14 The DDRC established this 
clinic as a base for its activities in the region. The 
clinic provides clinical and educational service on 
GI diseases to the local population. In this latter 
study, Aras investigators looked at the anatomical 
site distribution of the upper GI cancers diagnosed 
over a twenty-one-month period in Ardabil. The 
only gastroenterologist working in the region 
diagnosed four-hundred and ninety-nine upper GI 
cancers in 3,119 endoscopies done for various 
upper GI complaints. Of these 282 were gastric 
cancers. Most of these were located in the cardia 
(44%) followed by the antrum (29%), and the 
corpus (26%). This is in accord with the western 
trend of proximal migration of gastric cancers over 
the past half century, but interestingly the 
incidence of cardia cancer in Ardabil seems to be 
several orders higher than that reported from some 
western countries such as Scotland. The same 
group also looked at the axial view of the location 
of the cardia cancers. They observed that of the 
125 cardia cancers identified, 53 were located on 
the right side (along the lesser curve of the 
stomach), seven on the left side (along the fundus), 
and the rest were circumferential. Therefore, of the 
60 noncircumferential cardia cancers, 88% were 
located on the right side i.e. along the lesser 
curvature. This may be explained by the old theory 
of “canalis gastricus” or “magenstrasse” which 
implies that most of the liquid ingested by humans 
travel to the stomach along the lesser curvature 
side of the esophagus. Therefore if a luminal 
carcinogen is responsible for development of 
gastric cancer, it has a higher chance of being in 
contact with the lesser curve side of the stomach 
and cardia rather the right side. Although, this 
finding is of doubtful clinical significance at the 
time being, but it may have pathophysiological 
importance. These investigators’ figures show a 
male to female ratio of 1.1 and 1.3 for cardia and 
noncardia gastric cancers, respectively. Similar 
data reported from Europe show a reverse ratio 
(0.45 and 0.35, respectively). 
In searching for the possible etiologies of 
increased upper GI cancer incidence in Ardabil, 
Nouraie et al looked at the level of selenium, a 
supposedly important trace element in 
carcinogenesis in the upper GI tract.15 They 
showed that only 29% of the Ardabil population 
had a serum selenium concentration of more than 
90 µg/L. Therefore, selenium deficiency may be 
responsible  for  a  part  of   the  upper  GI   cancers  
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found in the region. This is a preliminary study and 
needs confirmation in further well-designed 
studies. 
Another interesting carcinogenesis theory is the 
nitrate and nitrosamine story. Nitrates have 
increased in our food by various means over the 
past few decades. We are using efficient methods, 
including nitrate containing fertilizers, to meet the 
growing need of the community for crops and 
agricultural products. Can this be somehow linked 
to the biological changes happening in our 
stomachs? Ardabil is an agricultural area, therefore 
considering such an explanation, one should look 
carefully at the local environmental changes. 
 
Conclusion  
Upper GI cancers are the leading cause of 
cancer deaths in our country. According to the 
current information, parts of our country harbor a 
rather high incidence for these cancers, comparable 
to the highest incidences ever reported in the 
world. Considering the changing trends in this 
process, it may be a unique opportunity for 
investigators to record the pattern of change and 
look for possible underlying causes and risk 
factors. Is the more westernized way of living 
causing this change? Is there anything special to 
the habits and lifestyle of the people, which is 
responsible? Does it have anything to do with 
genetics and molecular aspects of life in the 
region? Can there be any link between 
environmental factors and the risk of cancer found 
in the region? Should all people in this high-risk 
areas be looked for HP and be treated as a means 
of prevention of cancer? These and many more 
unanswered questions are the focus of ongoing 
large-scale studies being performed in Ardabil and 
other parts of northern Iran. For the present time it 
can only be said that upper GI cancers are the 
leading cause of cancer deaths in our country and 
especially in regions like Ardabil, and that 
proximal gastric cancers (e.g. cardia cancers) and 
esophageal adenocarcinomas are rising. 
Thoughtfully designed epidemiological and 
clinical studies are pivotal to unravel the details of 
why and how these are happening and help to plan  
what should be done to combat effectively with 
these still deadly diseases.  
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